InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,878.80
(
-0.73%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.22
(
-0.39%
)
Bitcoin
64,029.01
(
-3.59%
)
Post# of 251589
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: dia76ca post# 133910

Thursday, 12/29/2011 7:37:44 PM

Thursday, December 29, 2011 7:37:44 PM

Post# of 251589
FWIW, it isn't just Dew. We worked up Peregrine back in June 2010 and passed on it because of insufficiency of their earlier trials. We thought the risk too high until after the current crop of Phase II data were in.

When we pass on a company we usualy don't write it up, but we did on this one.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up